About Luminex Corporation
Luminex Corporation was incorporated in May 1995 and began commercial production of our first generation system in 1997. Luminex® (NASDAQ: LMNX) develops, manufactures and markets innovative biological testing technologies with applications throughout the life science and diagnostic industries. The company’s open-architecture xMAP® Technology enables large numbers of biological tests (bioassays) to be conducted and analyzed quickly, cost-effectively and accurately. Systems using xMAP Technology perform discrete bioassays on the surface of color-coded beads known as microspheres, which are then read in a compact analyzer. Using lasers and high-speed digital-signal processors, the analyzer simultaneously identifies the bioassay and measures the results, all in real time. Luminex Vision Statement Worldwide Leader in Multiplexed Solutions Specialties Molecular Diagnostics, xMAP Technology, Life Science Research, Multiplexing
Luminex Corporation Job Openings
Create job profile to receive interview calls for your dream job
Create Job Alert Kick Start! your career with best matching jobs
Location

X